{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:31:22Z","timestamp":1791066682549,"version":"4.1.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,1,30]],"date-time":"2013-01-30T00:00:00Z","timestamp":1359504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,1,30]],"date-time":"2013-01-30T00:00:00Z","timestamp":1359504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s10637-013-9929-8","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T09:26:26Z","timestamp":1359451586000},"page":"967-973","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["A phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket- directed SRC inhibitor, in patients with advanced malignancies"],"prefix":"10.1007","volume":"31","author":[{"given":"Aung","family":"Naing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace K.","family":"Dy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyn","family":"Dyster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Hangauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Fetterly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razelle","family":"Kurzrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex A.","family":"Adjei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,30]]},"reference":[{"issue":"4","key":"9929_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1023\/A:1023772912750","volume":"22","author":"JM Summy","year":"2003","unstructured":"Summy JM, Gallick GE (2003) SRC family kinases in tumor progression and metastasis. Cancer Metastasis Rev 22(4):337\u2013358","journal-title":"Cancer Metastasis Rev"},{"issue":"5","key":"9929_CR2","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1634\/theoncologist.2010-0408","volume":"16","author":"LN Puls","year":"2011","unstructured":"Puls LN, Eadens M, Messersmith W (2011) Current status of SRC inhibitors in solid tumor malignancies. Oncologist 16(5):566\u2013578","journal-title":"Oncologist"},{"issue":"2","key":"9929_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10549-011-1513-3","volume":"132","author":"M Anbalagan","year":"2012","unstructured":"Anbalagan M, Carrier L, Glodowski S, Hangauer D, Shan B, Rowan BG (2012) Kx-01, a novel SRC kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor alpha positive breast cancer. Breast Canc Res Treat 132(2):391\u2013409","journal-title":"Breast Canc Res Treat"},{"issue":"10","key":"9929_CR4","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.1016\/j.ejmech.2011.07.050","volume":"46","author":"A Fallah-Tafti","year":"2011","unstructured":"Fallah-Tafti A, Foroumadi A, Tiwari R, Shirazi AN, Hangauer DG, Bu Y, Akbarzadeh T, Parang K, Shafiee A (2011) Thiazolyl n-benzyl-substituted acetamide derivatives: synthesis, SRC kinase inhibitory and anticancer activities. Eur J Med Chem 46(10):4853\u20134858","journal-title":"Eur J Med Chem"},{"issue":"7","key":"9929_CR5","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s10620-008-0519-0","volume":"54","author":"GM Lau","year":"2009","unstructured":"Lau GM, Yu GL, Gelman IH, Gutowski A, Hangauer D, Fang JW (2009) Expression of SRC and FAK in hepatocellular carcinoma and the effect of SRC inhibitors on hepatocellular carcinoma in vitro. Dig Dis Sci 54(7):1465\u20131474","journal-title":"Dig Dis Sci"},{"issue":"6","key":"9929_CR6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/jnci\/91.6.523","volume":"91","author":"K James","year":"1999","unstructured":"James K, Eisenhauer E, Christian M, Terenziani M, Vena D, Muldal A, Therasse P (1999) Measuring response in solid tumors: unidimensional versus bidimensional measurement. J Natl Canc Inst 91(6):523\u2013528","journal-title":"J Natl Canc Inst"},{"issue":"21","key":"9929_CR7","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.1182\/blood-2012-03-418582","volume":"119","author":"A Zarbock","year":"2012","unstructured":"Zarbock A (2012) The shady side of dasatinib. Blood 119(21):4817\u20134818","journal-title":"Blood"},{"issue":"Suppl 1","key":"9929_CR8","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1097\/IGC.0b013e318251c8e3","volume":"22","author":"T Mould","year":"2012","unstructured":"Mould T (2012) An overview of current diagnosis and treatment in ovarian cancer. Int J Gynecol Canc Official J I Gynecol Canc Soc 22(Suppl 1):S2\u2013S4","journal-title":"Int J Gynecol Canc Official J I Gynecol Canc Soc"},{"key":"9929_CR9","first-page":"371","volume":"6","author":"JA Yared","year":"2012","unstructured":"Yared JA, Tkaczuk KH (2012) Update on taxane development: new analogs and new formulations. Drug Des Dev Ther 6:371\u2013384","journal-title":"Drug Des Dev Ther"},{"issue":"4","key":"9929_CR10","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1158\/1541-7786.MCR-09-0178","volume":"8","author":"EL Leung","year":"2010","unstructured":"Leung EL, Wong JC, Johlfs MG, Tsang BK, Fiscus RR (2010) Protein kinase g type ialpha activity in human ovarian cancer cells significantly contributes to enhanced src activation and DNA synthesis\/cell proliferation. Mol Canc Res MCR 8(4):578\u2013591","journal-title":"Mol Canc Res MCR"},{"issue":"4","key":"9929_CR11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.4161\/cbt.12.4.16430","volume":"12","author":"XF Le","year":"2011","unstructured":"Le XF, Bast RC Jr (2011) SRC family kinases and paclitaxel sensitivity. Canc Biol Ther 12(4):260\u2013269","journal-title":"Canc Biol Ther"},{"issue":"3","key":"9929_CR12","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1158\/0008-5472.CAN-10-1605","volume":"71","author":"H Cai","year":"2011","unstructured":"Cai H, Babic I, Wei X, Huang J, Witte ON (2011) Invasive prostate carcinoma driven by c-SRC and androgen receptor synergy. Cancer Res 71(3):862\u2013872","journal-title":"Cancer Res"},{"issue":"2","key":"9929_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10585-011-9436-2","volume":"29","author":"L Rice","year":"2012","unstructured":"Rice L, Lepler S, Pampo C, Siemann DW (2012) Impact of the SRC inhibitor dasatinib on the metastatic phenotype of human prostate cancer cells. Clin Exp Metastasis 29(2):133\u2013142","journal-title":"Clin Exp Metastasis"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-013-9929-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-013-9929-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-013-9929-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-013-9929-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T23:37:02Z","timestamp":1678491422000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-013-9929-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,30]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["9929"],"URL":"https:\/\/doi.org\/10.1007\/s10637-013-9929-8","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,30]]},"assertion":[{"value":"13 December 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}